Carlo Gambacorti Passerini, professore associato di Medicina Interna presso l’Università di Milano Bicocca, conduce attività clinica nell’Unità di Ematologia dell’Ospedale San Gerardo di Monza ed è responsabile dell’Unità di Ricerca Clinica dello stesso Ospedale. Il gruppo da lui diretto presso l’Università di Milano-Bicocca lavora da alcuni anni alla ricerca preclinica sul linfoma ALK e ha già prodotto importanti contributi nella conoscenza di questa patologia. Le sue ricerche sono finanziate in parte dall’Associazione Italiana per la Ricerca sul Cancro (AIRC) e dalla Fondazione Cariplo.
%22%20transform%3D%22translate(.7%20.7)%20scale(1.36719)%22%20fill-opacity%3D%22.5%22%3E%3Cellipse%20fill%3D%22%23fefefe%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-118.18482%20-46.30723%2020.81895%20-53.1339%20168.5%20181)%22%2F%3E%3Cellipse%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(141.54444%2064.95726%20-24.94429%2054.3546%20206.1%2040.7)%22%2F%3E%3Cellipse%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-15.63959%2039.32179%20-124.4427%20-49.49502%20217.7%2034)%22%2F%3E%3Cpath%20fill%3D%22%239f9f9f%22%20d%3D%22M234%20160L-16-15l66%20143z%22%2F%3E%3Cellipse%20fill%3D%22%23eee%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(13.95541%2070.4175%20-34.04928%206.74792%20114.1%20181)%22%2F%3E%3Cellipse%20fill%3D%22%23171717%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-15.06932%20-48.5855%2025.938%20-8.04495%200%20149.2)%22%2F%3E%3Cellipse%20fill%3D%22%23505050%22%20cx%3D%22188%22%20cy%3D%22113%22%20rx%3D%2239%22%20ry%3D%2239%22%2F%3E%3Cellipse%20fill%3D%22%23c8c8c8%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(10.11584%2019.22056%20-68.60466%2036.10686%20219.1%20172.3)%22%2F%3E%3Cellipse%20fill%3D%22%23b2b2b2%22%20cx%3D%22102%22%20cy%3D%22114%22%20rx%3D%2241%22%20ry%3D%2228%22%2F%3E%3Cellipse%20cx%3D%22247%22%20cy%3D%2230%22%20rx%3D%2234%22%20ry%3D%2234%22%2F%3E%3Cellipse%20fill%3D%22%238f8f8f%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(13.85031%201.79884%20-9.3912%2072.30817%2058.2%20136.6)%22%2F%3E%3Cellipse%20fill%3D%22%23525252%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(-58.4%20104.7%20-79.2)%20scale(13.29686%2087.83397)%22%2F%3E%3Cpath%20fill%3D%22%23939393%22%20d%3D%22M174.4%20163.6l-3.7-23.7%2084.9-13.5%203.7%2023.7z%22%2F%3E%3Cellipse%20fill%3D%22%23898989%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(-132.6%2013.1%2014.6)%20scale(79.36827%2036.97273)%22%2F%3E%3Cellipse%20fill%3D%22%23ededed%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(28.9716%2016.04277%20-12.06545%2021.78897%20113%20173.3)%22%2F%3E%3Cpath%20fill%3D%22gray%22%20d%3D%22M162%2072l4%2090-47-101z%22%2F%3E%3Cpath%20fill%3D%22%23666%22%20d%3D%22M23%2099h35v59H23z%22%2F%3E%3Cpath%20fill%3D%22%23a8a8a8%22%20d%3D%22M77%20119l36-18-77-50z%22%2F%3E%3Cellipse%20fill%3D%22%233e3e3e%22%20cx%3D%22231%22%20cy%3D%22104%22%20rx%3D%2249%22%20ry%3D%2213%22%2F%3E%3Cellipse%20cx%3D%22253%22%20cy%3D%2231%22%20rx%3D%2233%22%20ry%3D%2233%22%2F%3E%3C%2Fg%3E%3C%2Fsvg%3E)
Tutti gli articoli
SCOPERTA/ L’ultima novità contro il tumore dalla ricerca italiana
Risultati incoraggianti arrivano da una ricerca sulla molecola crizotinib condotta in Italia. Ce ne parla uno degli autori, CARLO GAMBACORTI ...
